805 Oncolytic adenovirus encoding human interleukin-7 in combination with ICIs as a treatment strategy against renal cell carcinoma (RCC)

• Akseli Hemminki,
• Víctor Cervera-Carrascón,
• Otto Hemminki,
• João Manuel Santos,
• Saru Basnet,
• Santeri A Pakola,
• James Clubb,
• Elise Jirovec,
• Dafne CA Quixabeira,
• Tatiana Kudling,
• Lyna Haybout,
• Susanna AM Grönberg-Vähä-Koskela,
• Victor Arias

Affiliations

Akseli Hemminki

3TILT Biotherapeutics, Helsinki, Finland

Víctor Cervera-Carrascón

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Otto Hemminki

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

João Manuel Santos

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Saru Basnet

1University of Helsinki, Helsinki, Finland

Santeri A Pakola

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

James Clubb

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Elise Jirovec

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Dafne CA Quixabeira

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Tatiana Kudling

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Lyna Haybout

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Susanna AM Grönberg-Vähä-Koskela

4Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland

Victor Arias

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland